cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Anixa Biosciences Inc
4 own
4 watching
Current Price
$0
$0.05
(1.22%)
logo-anix
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
138.96M
52-Week High
52-Week High
6.2491
52-Week Low
52-Week Low
2.3
Average Volume
Average Volume
0.02M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization138.96M
icon52-Week High6.2491
icon52-Week Low2.3
iconAverage Volume0.02M
iconDividend Yield--
iconP/E Ratio--
What does the Anixa Biosciences Inc do?
Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company s therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the treatment of ovarian cancer; and the discovery and development of anti-viral drug candidates for the treatment of COVID-19 focused on inhibiting certain protein functions of the virus. Its vaccine programs comprise the development of a vaccine against triple negative breast cancer; and a preventative vaccine against ovarian cancer. The company is also developing immuno-therapy drugs against cancer. It has a collaboration agreement with MolGenie GmbH to discover and develop anti-viral drug candidates against COVID-19. The company was formerly known as ITUS Corporation and changed its name to Anixa Biosciences, Inc. in October 2018. Anixa Biosciences, Inc. was incorporated in 1982 and is based in San Jose, California.
Read More
How much money does Anixa Biosciences Inc make?
News & Events about Anixa Biosciences Inc.
PR Newswire
1month ago
Anixa Biosciences to Present at Biotech Showcase 2023 Anixa Biosciences to Present at Biotech Showcase 2023 PR Newswire SAN JOSE, Calif., Dec. 19, 2022 SAN JOSE, Calif., Dec. 19, 2022 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and...
PR Newswire
3 months ago
Dr. Jose Conejo-Garcia, Invited to Present Keynote Address at Duke Cancer Institute, will Discuss Anixa Biosciences' Ovarian Cancer CAR-T Therapy Dr. Jose Conejo-Garcia, Invited to Present Keynote Address at Duke Cancer Institute, will Discuss Anixa Biosciences' Ovarian Cancer CAR-T Therapy PR...
PR Newswire
3 months ago
Anixa Biosciences Announces Commencement of Phase 1b Trial of its Breast Cancer Vaccine at Cleveland Clinic Anixa Biosciences Announces Commencement of Phase 1b Trial of its Breast Cancer Vaccine at Cleveland Clinic PR Newswire SAN JOSE, Calif., Oct. 26, 2022 SAN JOSE, Calif., Oct. 26, 2022...
PR Newswire
3 months ago
Anixa Biosciences Announces Presentation on Ovarian Cancer CAR-T Therapy Trial at the Society for Immunotherapy of Cancer (SITC) Annual Meeting Anixa Biosciences Announces Presentation on Ovarian Cancer CAR-T Therapy Trial at the Society for Immunotherapy of Cancer (SITC) Annual Meeting PR Newswire...
PR Newswire
4 months ago
Anixa Biosciences' Ovarian Cancer CAR-T Therapy to be Presented at the Rivkin Center & American Association of Cancer Research (AACR) 14th Biennial Ovarian Cancer Research Symposium Anixa Biosciences' Ovarian Cancer CAR-T Therapy to be Presented at the Rivkin Center & American...
Frequently Asked Questions
Frequently Asked Questions
What is Anixa Biosciences Inc share price today?
plus_minus_icon
Can Indians buy Anixa Biosciences Inc shares?
plus_minus_icon
How can I buy Anixa Biosciences Inc shares from India?
plus_minus_icon
Can Fractional shares of Anixa Biosciences Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Anixa Biosciences Inc stocks?
plus_minus_icon
What is today’s traded volume of Anixa Biosciences Inc?
plus_minus_icon
What is today’s market capitalisation of Anixa Biosciences Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Anixa Biosciences Inc?
plus_minus_icon
What percentage is Anixa Biosciences Inc down from its 52-Week High?
plus_minus_icon
What percentage is Anixa Biosciences Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$0
$0.05
(1.22%)
logo-anix
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
Bioventus Inc
Bioventus Inc
$2.26
$0.27 (13.57 %)
Apyx Medical Corp
Apyx Medical Corp
$3.50
$0.44 (14.38 %)
Genetron Holdings Ltd - ADR
Genetron Holdings Ltd - ADR
$1.16
$-0.01 (-0.87 %)
Asensus Surgical Inc
Asensus Surgical Inc
$0.76
$0.02 (2.73 %)
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.
Related Stocks
Bioventus Inc
Bioventus Inc
$2.26
$0.27 (13.57 %)
Apyx Medical Corp
Apyx Medical Corp
$3.50
$0.44 (14.38 %)
Genetron Holdings Ltd - ADR
Genetron Holdings Ltd - ADR
$1.16
$-0.01 (-0.87 %)
Asensus Surgical Inc
Asensus Surgical Inc
$0.76
$0.02 (2.73 %)
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00